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Abstract
Background: A range of innovative websites, mobile technologies, eHealth and mHealth platforms have emerged to support
adolescents and young adults (AYAs) with cancer. Previous reviews have identified these various applications and solutions, but
no review has summarized the quality, feasibility, and efficacy of existing patient platforms (inclusive of websites, mobile
technologies, mHealth and eHealth platforms) developed specifically for young people with cancer.
Objective: This paper describes the design of a protocol to conduct a review of published studies or reports which describe or
report on an existing platform designed specifically for AYAs who have had a cancer diagnosis.
Methods: A search string was developed using a variety of key words and Medical Subject Heading and applied to bibliographic
databases. General data (sample characteristics, patient platform development, design and, if applicable, pilot testing outcomes)
will be extracted from reports and studies. Drawing on a previously developed coding schematic, the identified patient platforms
will be coded for mode of delivery into (1) automated functions, (2) communicative functions, and (3) use of supplementary
modes. An adapted version of the Mobile App Rating Scale (MARS) will be used to assess the of quality of each identified patient
platform. The methodological quality of included studies will be assessed using the Quality Assessment Criteria for Evaluating
Primary Research Papers from a Variety of Fields (QualSyst). Both authors will independently screen eligible studies for final
inclusion and will both be responsible for data extraction and appraisal. Data will be synthesized narratively to provide an overview
of identified patient platforms.
Results: The review began in October 2016 and is currently in progress. The review paper will be submitted for peer-review
and publication in the summer of 2017.
Conclusions: This review will be unique in its focus on assessing, where possible, the quality and efficacy of patient platforms
for adolescents and young adults diagnosed with cancer. Results generated from this review will provide an invaluable insight
into the utility of modern technology in supporting young people with cancer.
(JMIR Res Protoc 2017;6(1):e4)   doi:10.2196/resprot.6597
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Introduction
Specifically as a cancer diagnosis and its subsequent treatment
may be the first time a young person independently encounters
the health care system and is required to learn self-management
skills relating to their health and well-being. Each year
approximately 14,000 adolescents and young adults (AYAs)
are diagnosed with cancer within Europe [1]. Although this
number accounts for only a small proportion of the total cancer
diagnoses that occur annually, young people with cancer have
unique care needs and require tailored support from the point
of diagnosis, during treatment, and throughout their lifetime as
survivors of cancer [2-4]. AYAs who have had a cancer
diagnosis are at increased risk of cancer recurrence, chronic
disease, and often face physical, emotional, and social
difficulties [5,6]. Specifically, time spent in hospital can disrupt
normal social and educational milestones and common
treatment-related side-effects such as hair loss, weight gain,
scarring, infertility, and amputation can often impact a young
person’s body image, trust in health, and self-esteem [6,7].
Following successful cancer treatment more than 60% of AYA
survivors of cancer will experience at least 1 long-term chronic
health problem as a result of their original diagnosis and
treatment [8]. Addressing the specific care needs of young
people with cancer has been at the heart of the AYA cancer
profession since its inception in the early 1990s [9].
Internationally, efforts and advancements in research, policy,
and care are continually being made to ensure young people
with cancer receive the specific medical, emotional, and practical
support they require during cancer treatment and beyond
[1,5,10]. A cancer diagnosis and its subsequent treatment may
be the first time a young person independently encounters the
health care system and is required to learn self-management
skills relating to their health and wellbeing.
Within this context, websites, mobile technologies, and eHealth
platforms have emerged as promising and innovative strategies
for assisting young people with cancer in accessing
information-rich environments and accessing support suitable
to their needs [11]. Such technologies offer potential
opportunities for AYA survivors of cancer to self-monitor or
self-assess their health needs and access peer-to-peer support
in a safe environment. Moreover, remote-based health
interventions overcome geographical and time-constraint barriers
typically faced by health care professionals and researchers
attempting to engage this population [12]. A previous review
of mobile and tablet-based apps available to young people with
cancer identified 7 apps in total [13]. Of these 7 apps, the
majority were piloted in proof-of-concept investigations among
only a small sample of young people. Despite noted limitations
like this coupled with a lack of empirical testing of the identified
apps, Wesley and Fizur (2015) concluded that apps were a
favorable means of health intervention for young people with
cancer due to the positive perceptions of the usability of the
apps and their functionalities [13]. This is reflective of previous
studies which report high levels of desire for technology-based
information resources and self-management tools among AYAs
living with or beyond a diagnosis of cancer [11,12].
However, to date there has been no focused effort to fully
synthesize and review existing patient platforms (inclusive of
websites, mobile technologies, and mHealth and eHealth
platforms) developed specifically for young people with cancer.
Understanding component features of existing technology
platforms is an important step in characterizing the potential
utility of technology-based interventions for young people with
cancer. Thus, the aim of this review protocol is to outline the
staged approach that will be adopted to address this knowledge
gap. The objective of the review is to identify, characterize, and
fully assess the quality, feasibility, and efficacy of existing
patient platforms developed specifically for adolescents and
young adults who have had a cancer diagnosis. Such a
comprehensive review will provide further important insight
into the utility of technology in the health care and support of
AYAs with cancer.
Methods
The methods to be adopted in this literature review are outlined
below and follow the standard Preferred Reporting Items for
Systematic Review and Meta-Analysis Protocols guidance [14].
Inclusion Criteria
Types of Studies and Reports
Any study or report which describes or reports an existing
electronic platform designed specifically for young people aged
between 13 and 39 years of age living with or beyond a cancer
diagnosis will be included for review.
Types of Participants
The age range of 13 to 39 years has been used to reflect United
Kingdom and United States of America accepted definitions of
young people with cancer [15,16]. Participants of interest are
those who fall within this age bracket and are defined as
teenagers, adolescents, or young adults living with or beyond
cancer. This includes young people who are AYA-aged
survivors of a childhood cancer diagnosis. No studies will be
excluded based upon participants’ treatment status or position
on the cancer care continuum. This aligns with the National
Cancer Institute, World Cancer Research Fund, and American
Institute of Cancer Research definitions of cancer survivor as
anyone who has had cancer from the point of diagnosis onwards
[17,18].
Types of Interventions
Patient platforms for the purposes of this review will encompass
any eHealth, mHealth, or health informatics efforts which apply
modern computing and communication methods such as digital
technologies for the provision of health care.
Types of Outcome Measures
The efficacy of patient platforms piloted as health interventions
within randomized controlled trials or quasi-experimental trials
will be assessed by extracting data on health outcomes,
specifically the magnitude of change in health outcome.
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Exclusion Criteria
Studies or reports will be excluded from the review if they report
on platforms developed for young people with comorbid
conditions other than cancer or if AYAs with cancer are not the
primary focus of the paper (ie, where AYAs with cancer are
included as a subsample of AYAs more generally or AYAs with
other illness conditions). In addition, studies or reports with
insufficient detail on the target population, intervention, and
mode of delivery (even after author contact to clarify) will be
excluded from the review. Studies investigating patient platforms
designed for adult cancer survivors aged 40 years and older and
studies where the mean age of the sample is older than 39 years
will also be excluded. Likewise, electronic platforms designed
for use exclusively by parents or caregivers and health care
professionals who work directly with AYA cancer patients will
be not be included in the final review.
Identification and Screening
A literature search for patient platforms developed specifically
for or piloted among AYAs who have had a cancer diagnosis
will be conducted. The search string outlined below will be
applied to bibliographic databases. Where possible, authors of
studies selected for review will be contacted to inquire as to
whether they know of any additional patient platforms designed
specifically for AYAs living with or beyond a diagnosis of
cancer, either published or unpublished.
The search strategy includes a range of Medical Subject
Headings terms and a range of relevant keywords for the
interventions of interest in this review. Grey literature and the
reference lists of all included papers and reports will also be
reviewed to identify any additional relevant studies or reports.
Search String: Teen* OR Adolesc* OR Young Adult OR Child
AND Cancer OR Cancer Survivor AND app OR apps OR
application or mobile OR Android OR droid OR iphone OR ios
OR blackberry or web OR internet OR portal OR portlet OR
microsite OR website OR “web site” OR url OR mhealth OR
ehealth OR internet OR online OR digital OR email OR social
network OR electronic communication OR e-health OR
e-learning OR elearning OR social network OR facebook OR
myspace OR virtual world OR short messaging service OR
virtual clinic OR computer assisted therapy OR information
technology OR electronic communication OR digital divide OR
e-mail OR email OR telehealth.
Evaluation Criteria
Data will be extracted, appraised, and evaluated to allow a
comprehensive synthesis of included studies and reports.
Data Extraction
General data and information regarding sample characteristics,
patient platform development, design, and (if applicable) pilot
testing outcomes will be extracted from reports and studies.
Coding of Platform Characteristics
Mode of delivery will be coded based upon the coding scheme
developed by Webb and colleagues [19]. Automated functions
will be classed as either (1) enriched information environment
(eg, supplementary materials, testimonials videos, or games),
(2) automated tailored feedback based upon individual progress
monitoring (eg, comparison to norms, goals, reinforcing
messages, or coping messages), or (3) automated follow up
messages (eg, reminders, tips, newsletters, and encouragement).
Communicative functions will be categorized into (1) access to
an advisor to request advice (eg, ask the expert/expert-led
discussions or chat functions), (2) scheduled contact with an
advisor (eg, emails), and (3) peer-to-peer support access.
Supplementary modes of communication will be classified into
email, telephone, short messaging service, CD-ROM, and
videoconferencing.
Assessment of Quality
An adapted version of the Mobile App Rating Scale (MARS)
will be used to evaluate each patient platform. The MARS scale
will be used to classify and evaluate each platform in 5 areas:
engagement, functionality, aesthetics, information quality, and
subjective quality [20].
The methodological quality of included studies will be assessed
using the Quality Assessment Criteria for Evaluating Primary
Research Papers from a Variety of Fields (QualSyst). This tool
incorporates scoring systems previously used for assessing
qualitative and quantitative research. There are 14 items to assess
quantitative studies and 10 items to assess qualitative studies.
Assessment of Feasibility and Efficacy
Data and information regarding reported acceptability,
compliance, delivery of the intervention, recruitment, and
participant retention will be extracted from each of the studies
and reports and synthesized in order to gather an overview of
the feasibility of each individual patient platform.
Data Synthesis
Extracted and appraised data will be collated in relevant Excel
tables (Microsoft Corp). Synthesis data will be presented
narratively in text and summary tables in the review publication.
Results
The review began in October 2016 and is currently in progress.
The review paper will be submitted for peer-review and
publication in the summer of 2017.
Discussion
The application of technology in the supportive care of AYAs
is an emerging field of interest [11]. To date, however, there
has been no collective effort to fully synthesize the literature
within this area or identify key features and functionalities of
existing patient platforms for AYAs with cancer. This
methodological review of eHealth, mHealth, or health
informatics efforts that apply modern computing and
communication methods for the provision of health care and
information to AYA cancer patients and survivors will allow
an invaluable insight into the range of existing patient platforms
for young people with cancer. Furthermore, the use of multiple
coding frameworks to classify and assess intervention features
will allow rigorous assessment of patient platform quality,
feasibility, and efficacy. This approach will provide a novel and
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comprehensive overview of this topical area. The participant
inclusion criteria of this review has purposefully been kept broad
in order to reflect international variations in AYA cancer age
brackets [15,21] and variations in the terminology used to
describe AYA cancer patients and cancer survivors [22].
Equally, the intervention inclusion criteria is broad in order to
fully capture the wide range of existing patient platforms for
this unique population group. This approach to searching
existing literature for studies concerning AYA cancer
populations has been previously applied within other systematic
reviews [23,24]. It is hoped this review will provide an
invaluable insight into existing patient platforms and underscore
future developments within this field of cancer research.
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